| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/06/1995 | WO1995008991A1 Parenteral busulfan for treatment of malignant disease |
| 04/06/1995 | WO1995008990A1 Increasing aqueous humor outflow |
| 04/06/1995 | WO1995008987A1 Process for preparation of solid disperions and deposits as well as of solid medicinal forms with dihydropyridine type calcium antagonists |
| 04/06/1995 | WO1995008986A1 Camptothecin formulations |
| 04/06/1995 | WO1995008985A1 Perfluorocarbons as anti-inflammatory agents |
| 04/06/1995 | WO1995008920A1 Substantive antimicrobial phosphates |
| 04/06/1995 | WO1995003830A3 Prodrugs of farnesyl transferase inhibitors for adept or vdept |
| 04/06/1995 | WO1994028895A3 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| 04/06/1995 | DE4435114A1 Insecticide and insect repellent compositions |
| 04/06/1995 | DE4333794A1 Acetylsalicylic acid derivatives for controlling states of inflammation and pain and for the prophylaxis and therapy of thrombosis |
| 04/06/1995 | CA2172978A1 Arteriosclerosis remedy |
| 04/06/1995 | CA2172958A1 Anthracene derivatives for use as anticancer agent or dye |
| 04/06/1995 | CA2172601A1 Perfluorocarbons as anti-inflammatory agents |
| 04/06/1995 | CA2172393A1 Methods of stimulating phagocytosis |
| 04/06/1995 | CA2172126A1 Inhibitors of farnesyl-protein transferase |
| 04/06/1995 | CA2172125A1 Inhibitors of farnesyl-protein transferase |
| 04/06/1995 | CA2171553A1 Using antisense oligonucleotides to modulate nerve growth and to reverse .beta./a4 amyloid-induced morphology |
| 04/06/1995 | CA2168846A1 Ranitidine and calcium carbonate pharmaceutical combination product |
| 04/06/1995 | CA2167526A1 Monoglyceride/lactate ester permeation enhancer |
| 04/06/1995 | CA2165802A1 Monoglyceride/lactate ester permeation enhancer for oxybutynin |
| 04/06/1995 | CA2149657A1 Compositions containing growth factors and antiplastic agents |
| 04/06/1995 | CA2149528A1 Compositions containing growth factors and antimetabolites |
| 04/06/1995 | CA2133614A1 Retinol containing anhydrous and stable cosmetic or pharmaceutical composition for skin and use thereof for the treatment of skin diseases |
| 04/06/1995 | CA2133281A1 Estradiol derivative-alkylating agent conjugate with reduced hormonal activity, process for preparing the same, compounds useful for the preparation thereof, and growth inhibitingcomposition containing the conjugate or estradiol derivative |
| 04/05/1995 | EP0646596A1 Nucleic acid binding oligomers having C-branches for therapy and diagnosis |
| 04/05/1995 | EP0646595A1 Nucleic acid binding oligomers having C-branches for therapy and diagnosis |
| 04/05/1995 | EP0646593A1 Corticoid-17,21-dicarboxylic acid ester and corticosteroid-17-carboxylic acid ester-21-carbonic, process for their production and medicaments containing them |
| 04/05/1995 | EP0646592A1 Estradiol derivative-alkylating agent conjugate |
| 04/05/1995 | EP0646586A1 2-aminoethanesulfonic acid/zinc complex compound |
| 04/05/1995 | EP0646583A1 Derivatives of Imidezol-4-yl piperidine, their preparation and use in therapy |
| 04/05/1995 | EP0646582A1 Useful hemi-hydrate form of a cerebral function enhancing agent |
| 04/05/1995 | EP0646578A1 Phenyl carboxamide-isoxazole-derivatives and salts, process for their preparation, their use as pharmaceuticals, and pharmaceutical compositions containing them |
| 04/05/1995 | EP0646576A1 Vitamin D3-analogs |
| 04/05/1995 | EP0646569A1 Novel carboxylate derivatives exhibiting phospholipase A2 inhibitory activity |
| 04/05/1995 | EP0646374A1 Double-coated oxcarbazepine containing tablets |
| 04/05/1995 | EP0646373A2 Inhibitor of Epstein-Barr virus expression |
| 04/05/1995 | EP0646372A1 Medicine containing capsaicin for the treatment of chronic rhinopathy |
| 04/05/1995 | EP0646371A1 Anhydrous cosmetic or pharmaceutical composition containing retinol |
| 04/05/1995 | EP0646368A1 A gel-resembling composition containing organopolysiloxane, without a gelling agent used in cosmetic and dermatology |
| 04/05/1995 | EP0646178A1 expression cassette with regularoty regions functional in the mammmlian host |
| 04/05/1995 | EP0646170A1 DIABETOGENE $i(rad): A TYPE II DIABETES SPECIFIC GENE |
| 04/05/1995 | EP0646126A1 Novel steroids with pregnane skeleton, pharmaceutical compositions containing them and process for preparing same |
| 04/05/1995 | EP0646125A1 1,5-anhydrohexitol nucleoside analogues and pharmaceutical use thereof |
| 04/05/1995 | EP0646119A1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque |
| 04/05/1995 | EP0646116A1 Process and intermediates for bis-aza-bicyclic anxiolytic agents |
| 04/05/1995 | EP0646115A1 Heterocyclic-cyclic amine derivatives |
| 04/05/1995 | EP0646114A1 5-(1,2,4-triazol-1-ylmethyl)-3h-isobenzofuran-1-one derivatives, their preparation and use as aromatase inhibitors |
| 04/05/1995 | EP0646112A1 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors |
| 04/05/1995 | EP0646110A1 N-substitued 3-azabicyclo 3.2.0]heptane derivatives useful as neuroleptic agents etc. |
| 04/05/1995 | EP0646012A1 Wound healing and treatment of fibrotic disorders |
| 04/05/1995 | EP0646009A1 Use of guanosine in the manufacture of drugs for the treatment of brain dysfunction |
| 04/05/1995 | EP0646008A1 Minimizing progestin associated breakthrough bleeding |
| 04/05/1995 | EP0646005A1 Methods for treating arteriosclerosis |
| 04/05/1995 | EP0646004A1 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease |
| 04/05/1995 | EP0645997A1 Cosmetic containing phospholipids and fluorocarbon compounds. |
| 04/05/1995 | EP0593639B1 Pyrrolidine and thiazolidine derivatives, preparation thereof and drugs containing same |
| 04/05/1995 | EP0565549B1 Use of 1,3-oxathiolane nucleoside analogues in the manufacture of a medicament for treatment of hepatitis b |
| 04/05/1995 | EP0561948B1 Phosphonic acid derivatives useful as antiinflammatory agents |
| 04/05/1995 | EP0544812B1 Bisphosphonic acid derivatives as anti-arthritic agents |
| 04/05/1995 | EP0536169B1 [3H,7H]THIAZOLO [3,4-a]PYRIDINES WITH ANTIASTHMATIC AND ANTIINFLAMMATORY ACTIONS ON THE RESPIRATORY TRACT |
| 04/05/1995 | EP0510151B1 Improved anti-plaque compositions comprising a combination of morpholinoamino alcohol and anti-microbial agent |
| 04/05/1995 | EP0431023B1 Gamma inulin compositions |
| 04/05/1995 | EP0365664B1 Use of synthetic l-carnitine in food for domestic dogs or cats |
| 04/05/1995 | CN1101047A Intermediates useful in the preparation of pyranyl cyanoguanidine derivatives and methods of preparing same |
| 04/05/1995 | CN1101046A 2-aminoalkyl-5-aminoalkylamino substituted isoquinoindazole-6(2h)-ones |
| 04/05/1995 | CN1101044A 2-(3-oxoalk(en)yl)-3-isothiazolones and derivatives as antimicrobial agents |
| 04/05/1995 | CN1101043A Process for preparing oxazole derivatives |
| 04/05/1995 | CN1101042A Process for preparing oxazole derivatives |
| 04/05/1995 | CN1101041A Process for preparing oxazole derivatives |
| 04/05/1995 | CN1101039A 哌嗪衍生物 Piperazine derivatives |
| 04/05/1995 | CN1100939A Lianhuangsong pill and capsule and its preparation method |
| 04/05/1995 | CN1100933A Hypoglycemic agents |
| 04/05/1995 | CN1100932A Use of the substituted azaspirane in the manufacture of a medieament for the treatment of psoriasis |
| 04/05/1995 | CN1100931A Treatment of viral infections |
| 04/05/1995 | CN1100930A Parmaceutical for treating disease of autoimmunization system |
| 04/05/1995 | CN1028106C Therapeutic nucleosides |
| 04/05/1995 | CN1028105C Piperidine compound and their preparation |
| 04/05/1995 | CN1028103C Piperidinyl benzimidazoles |
| 04/05/1995 | CN1028100C Method for preparation of amino ketones compound |
| 04/05/1995 | CN1028099C W-phenoxy-heterocyclic compounds |
| 04/05/1995 | CA2133513A1 Gel like organopolysiloxane composition without gelling agent, useful in cosmetic and dermatological applications |
| 04/05/1995 | CA2133491A1 Imidazol-4-ylpiperidine derivatives, their preparation and their application in therapeutics |
| 04/05/1995 | CA2117669A1 Useful hemi-hydrate form of a cerebral function enhancing agent |
| 04/04/1995 | US5403953 1-phenylbicyclo[2.2.2]octane compounds |
| 04/04/1995 | US5403951 Crystalline modification of 2-dimethylaminoethyl-n-butylaminobenzoate hydrochloride, method for production thereof and pharmaceutical preparation for anaesthesia of eyes, based thereon |
| 04/04/1995 | US5403940 Vitamin D compound, method of preparing this compound and intermediate thereof |
| 04/04/1995 | US5403933 Indolizine derivatives, with pharmaceutical activity |
| 04/04/1995 | US5403930 Substituted salicylic acids |
| 04/04/1995 | US5403928 Fluorescent marker components and fluorescent probes |
| 04/04/1995 | US5403921 Drinking a solution of glycerol and water two hours before exertion and continuing until one-half hour before starting; phsiological effects |
| 04/04/1995 | US5403867 Administering PGI2 derivatives, such as beraprost |
| 04/04/1995 | US5403862 Administering partially lipophilic polyaminocarboxylic acid chelating agent |
| 04/04/1995 | US5403861 Treating or preventing nerve cell death |
| 04/04/1995 | US5403858 Perfusion solution ethanol free; antitumor agents |
| 04/04/1995 | US5403857 Enzyme inhibitors, antiallergens, antiinflammatory agents |
| 04/04/1995 | US5403854 Substituted N-heteroaryl -1,2-diaminocyclobutene-3,4-diones |
| 04/04/1995 | US5403853 Substituted N-aryl-1,2-diaminocyclobutene-3,4-diones |
| 04/04/1995 | US5403852 Oxazole derivatives, their preparation and pharmaceutical compositions containing them |
| 04/04/1995 | US5403851 Substituted tryptamines, phenalkylamines and related compounds |
| 04/04/1995 | US5403849 4-heterocyclophenyl-substituted dihydropyridines |